| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | Chief Operating Officer | Common Stock | 54,500 | $62,675 | $1.15 | 13 Mar 2025 | Direct |
| Opus Genetics, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 52,500 | 13 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | 13 Mar 2025 | 2 | $0 | 4 | Chief Operating Officer | 17 Mar 2025, 20:56 |
| IRD | Ocuphire Pharma, Inc. | 21 Mar 2024 | 1 | +$4,100 | 4 | Chief Operating Officer | 25 Mar 2024, 16:44 |
| IRD | Ocuphire Pharma, Inc. | 27 Nov 2023 | 1 | $0 | 4 | Chief Operating Officer | 27 Nov 2023, 18:24 |
| IRD | Ocuphire Pharma, Inc. | 27 Nov 2023 | 0 | $0 | 3 | Chief Operating Officer | 27 Nov 2023, 18:19 |